Novo Nordisk waves goodbye to VP in charge of device development

Kenneth Strømdahl has left Novo Nordisk after 17 year with the company. The past few years, he was responsible for the pharmaceutical company's Devices and Delivery Solutions division, where he oversaw more than 300 employees and the development of devices helping patients handle their diseases.

Photo: Novo Nordisk / PR

After 17 years in several positions at Novo Nordisk, Kenneth Strømdahl is off to pastures new.

Strømdahl writes in a post on Linkedin that effective today, he has left Novo Nordisk where he has since September 2015 been in charge of 300 employees under the title Senior Vice President, Devices & Delivery Solutions.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs